“…Oral gavage, 20 mg/kg/day dissolved in 2 ml saline (Sahin et al, 2019); Orally via catheter, 20 mg/kg (Tok et al, 2012) Ameliorated glomerular and tubular histology, decreased kidney expression of caspase-1 and fraction of TUNEL-positive cells (apoptosis) and kidney expression of NLRP3 and IL-1β (inflammation) in a rat model of diabetes (Sahin et al, 2019); reduced levels of lipid peroxidation and oxidative injury products in renal tissue, improved histological appearance in a rat I/R model (Tok et al, 2012) (Hattori et al, 2016) Ranitidine Blocker 36-94 ng/ml (IC50) Fed at 1.5 mg/30 g body weight Reduced renal damage and attenuated atherosclerosis in a HFD mouse model (Liu et al, 2020) Cimetidine Antagonist 70 nM (Ki) IP injection of 150 mg/kg (Estaphan et al, 2015); 0.25-1.2 mM addition to cell-free extract (Minai-Tehrani et al, 2011) Decreased creatinine, BUN, K + , Na + , NO, blood pressure creatine kinase, increased GFR, urine volume, and renal glutathione (Estaphan et al, 2015); improved renal function when used in combination with L-carnitine in a rat model of glycerol induced acute renal failure (Minai-Tehrani et al, 2011) epithelial cells equipped with histamine synthesis machinery. Thus, antagonism of histamine receptors has been proposed for the management of cardiac damage in hypertensive diseases (Potnuri et al, 2018).…”